These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14195481)

  • 21. [RELATION BETWEEN RETICULOCYTE LEVEL AND DIRECT COOMBS' TEST].
    GUAZELLI C
    Riv Clin Pediatr; 1963 Mar; 71():168-73. PubMed ID: 14076989
    [No Abstract]   [Full Text] [Related]  

  • 22. Haemolytic anaemia in the newborn infant.
    Walker W
    Clin Haematol; 1975 Feb; 4(1):145-66. PubMed ID: 810288
    [No Abstract]   [Full Text] [Related]  

  • 23. [IMMEDIATE AND LATE RESULTS OF HEMOLYTIC DISEASE OF THE NEWBORN FROM RH AND ABO FACTORS].
    DICAGNO L; LANGE MM; CASTELLO D
    Minerva Pediatr; 1963 Nov; 15():1207-35. PubMed ID: 14108674
    [No Abstract]   [Full Text] [Related]  

  • 24. [RESULTS OBTAINED IN THE TREATMENT OF MATERNAL-FETAL ABO AND RH INCOMPATIBILITY].
    GANDOLFOCARAMELLO MT; MARTINETTO G
    Minerva Pediatr; 1963 Nov; 15():1267-71. PubMed ID: 14108686
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of the Rh affected baby.
    Rice MS
    Australas Nurses J; 1975 May; 3(11):12, 19. PubMed ID: 806279
    [No Abstract]   [Full Text] [Related]  

  • 27. [ON THE PROPHYLAXIS OF HEMOLYTIC DISEASE OF THE NEWBORN DUE TO RH FACTORS].
    LANZONE P; VALENZI M
    Quad Clin Ostet Ginecol; 1963 Nov; 18():971-7. PubMed ID: 14106693
    [No Abstract]   [Full Text] [Related]  

  • 28. [INFLUENCE OF THE ABO BLOOD GROUP SYSTEM ON THE OCCURRENCE OF HEMOLYTIC DISEASE OF THE NEWBORN CAUSED BY RH INCOMPATIBILITY].
    BOSSI E
    Helv Paediatr Acta; 1964 Jun; 19():34-41. PubMed ID: 14189841
    [No Abstract]   [Full Text] [Related]  

  • 29. [ON DETERMINATION OF THE EFFECTIVENESS OF EXCHANGE TRANSFUSIONS IN THE NEWBORN].
    ROSTA J; LENKEI P
    Orv Hetil; 1964 Jul; 105():1300-6. PubMed ID: 14181905
    [No Abstract]   [Full Text] [Related]  

  • 30. [Mortality of newborn infants with hemolytic disease treated by exchange transfusion. Analysis of 524 cases].
    Polácek K
    Cesk Pediatr; 1967 Dec; 22(12):1059-66. PubMed ID: 4965949
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hemolytic disease of the newborn].
    Nakayama K; Fujisawa S
    Rinsho Byori; 1967; ():Suppl 14:61-70. PubMed ID: 4969613
    [No Abstract]   [Full Text] [Related]  

  • 32. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of determination of the blood groups and Rh factors after exchange transfusions in newborn infants].
    Avdeeva RA; Kopp VD; Vasil'eva AF
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):7-12. PubMed ID: 417341
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 35. [On a case of perinatal hemolytic jaundice caused by Rh factor incompatibility].
    MAGGIA O
    Minerva Nipiol; 1959; 9():86-90. PubMed ID: 14419826
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical picture and the course of infection in hemolytic disease of the newborn].
    Maszkiewicz W; Koralewska J; Bokrzycka-Krysiak K; Kupiec G
    Acta Haematol Pol; 1988; 19(1-2):99-103. PubMed ID: 3149119
    [No Abstract]   [Full Text] [Related]  

  • 37. Risks of blood incompatibility and severe jaundice.
    ALLEN FH
    Bull Acad Med N J; 1962 Sep; 8():168-71. PubMed ID: 14041791
    [No Abstract]   [Full Text] [Related]  

  • 38. [NEO-NATAL HEMOLYTIC JAUNDICE DUE TO COLD PAN-ANTIBODIES OF MATERNAL ORIGIN].
    GRISLAIN JR; MAINARD R; DE BERRANGER P
    Arch Fr Pediatr; 1963; 20():853-6. PubMed ID: 14049373
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinico-statistical evaluation of the early outcome of neonatal jaundice].
    Ferrari G; Ballario R
    Minerva Pediatr; 1970 Jul; 22(28):1394-6. PubMed ID: 4995663
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.